Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection

<p>Abstract</p> <p>Background</p> <p>Infection with HIV-1 results in marked immunologic insults and structural damage to the intestinal mucosa, including compromised barrier function. While the development of highly active antiretroviral therapy (HAART) has been a major advancement in the treatment...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Schunter Marco, Chu Hiutung, Hayes Timothy L, McConnell Delandy, Crawford Sean S, Luciw Paul A, Bengmark Stig, Asmuth David M, Brown Jennifer, Bevins Charles L, Shacklett Barbara L, Critchfield J
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2012-06-01
Serija:	BMC Complementary and Alternative Medicine
Teme:	Human immunodeficiency virus-1 (HIV-1) synbiotics probiotics prebiotics microbial translocation immune activation highly active antiretroviral therapy (HAART) combined antiretroviral therapy (CART) complementary therapy.
Online dostop:	http://www.biomedcentral.com/1472-6882/12/84
Oznake:	Označite Brez oznak, prvi označite!